CHEMULAR

Chemular, a specialized FDA regulatory consultancy established in 2015, is dedicated to assisting companies in navigating the intricate regulatory landscape for tobacco, nicotine, and related products. With over a decade of industry experience, Chemular provides expert guidance on Premarket Tobacco Applications (PMTAs) and other regulatory submissions. Chemular’s approach seamlessly integrates profound knowledge of FDA requirements with practical, results-driven strategies to enable clients to meet regulatory benchmarks efficiently and effectively. Our specialists manage every aspect of FDA submissions from inception to completion, ensuring that each project undergoes rigorous preparation for regulatory review. Compliance and meticulous attention to detail are paramount at every stage of the process.

Chemular offers comprehensive compliance services, encompassing full PMTA support, readiness for quality and manufacturing systems, tax compliance services, and strategic guidance on U.S. market entry. Our capabilities extend to product testing coordination, document preparation, data analysis, regulatory submissions, and ongoing FDA engagement. Additionally, Chemular provides operational support to align manufacturing practices with federal standards, facilitating a streamlined path to commercialization.

With a team of seasoned toxicologists, chemists, clinical experts, and regulatory strategists, Chemular has successfully submitted PMTAs for over 200 products and continues to guide companies through all phases of the PMTA and MRTP processes. For further information or to establish a connection with Chemular, please visit www.chemular.com.